BMS Does Not Think Pricing Or Monitoring Will Limit Camzyos Use

First-In-Class Drug’s List Price Is $89,500 Per Year

 
• By Mandy Jackson
  
Blood pressure test monitor with a stethoscope on a blue background
The Camzyos REMS requires monthly monitoring in the first three months then once every three months • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip